Literature DB >> 33488315

Are COVID fatalities in the US higher than in the EU, and if so, why?

Ainoa Aparicio1, Shoshana Grossbard2.   

Abstract

The COVID crisis has severely hit both the United States and Europe. We construct comparable measures of the death toll of the COVID crisis suffered by US states and 35 European countries: cumulative fatalities attributed to COVID at 100 days since the pandemic's onset in a particular nation/state. When taking account of demographic, economic, and political factors (but not health-policy related factors) we find that, controlling for population size, cumulative deaths are between 100 and 130% higher in a US state than in a European country. We no longer find a US/EUROPE gap in fatalities from COVID after taking account of how each nation/state implemented social distance measures. This suggests that various types of social distance measures such as school closings and lockdowns, and how soon they were implemented, help explain the US/EUROPE gap in cumulative deaths measured 100 days after the pandemic's onset in a state or country.
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021.

Entities:  

Year:  2021        PMID: 33488315      PMCID: PMC7811149          DOI: 10.1007/s11150-020-09532-9

Source DB:  PubMed          Journal:  Rev Econ Househ        ISSN: 1569-5239


Introduction

It is becoming increasingly common to compare Europe and the USA rather than the US and various European countries. For example, according to Richter (2020) “the trend of daily new COVID cases has taken completely different trajectories for the U.S. and the European Union.” COVID fatalities are also routinely compared across the two sides of the Atlantic. For example, Drum (2020) charted 7-day averages of daily deaths in the two unions, letting the US lag the EU by 12 days (reproduced in Fig. 1). It shows weekly mortality in the US in June 2020 lying substantially above that of the EU.
Fig. 1

Reproduced from K. Drum (2020). The graph represents average mortality rates (deaths per million inhabitants) over 7 consecutive days. For comparability, US data is lagged by 12 days

Reproduced from K. Drum (2020). The graph represents average mortality rates (deaths per million inhabitants) over 7 consecutive days. For comparability, US data is lagged by 12 days There are at least three problems with such comparisons. First, they ignore the enormous variation in COVID outcomes within Europe and within the US (see Table 1, showing cumulative deaths per million for 35 European countries and all 50 US states). To address this problem we analyze cumulative deaths from COVID in these 85 nations/states. In average population and a number of other characteristics, such as percent of the population aged 65 and older, US States tend to be similar to European countries (see Table 2). Second, a lag of 12 days between the average onset of COVID in the entire EU and its average onset in the entire US masks the great variation in onset dates among the 85 nations/states also reported in Table 1. France was first to experience a death from COVID, on February 15, 2020 (we define time of onset as the day a first death was recorded). Wyoming was the last to experience its first COVID death on April 13, almost two months later. To address this second problem we use statistics on reported COVID deaths 50 or 100 days after the onset of COVID in that nation/state.1 Looking at means we find a US/EUROPE gap of 207 more COVID-related deaths per million inhabitants 100 days after a nation/state’s first death: the mean number of deaths per million is 407 in a US state and 200 in a European country (see Table 2). These averages include New York (the nation/state with most deaths per million inhabitants) and Belgium ranking 7th in the list of all nations/states. A number of other European countries rank among the 20 most affected, but most top 20 nations/states are part of the US.2 The 5 nations/states with the best 100-days performance are all European countries (Malta, Greece, Latvia and Slovakia) except for Hawaii (see Table 1).
Table 1

Cumulative deaths from Coronavirus per capita 100 days after the onset of the coronavirus outbreak in that nation/state and date when country/state reached 100 days; observed by summer 2020

RankCountry/stateDeaths pc @100 daysReached 100 days on
1New York207222/06/2020
2New Jersey188818/06/2020
3Connecticut158026/06/2020
4Massachusetts152328/06/2020
5Rhode Island118106/07/2020
6Louisiana90722/06/2020
7Belgium84719/06/2020
8Michigan80626/06/2020
9Illinois73225/06/2020
10Delaware69204/07/2020
11Maryland68826/06/2020
12Pennsylvania67926/06/2020
13United Kingdom62715/06/2020
14Spain57813/06/2020
15Italy55502/06/2020
16Indiana52224/06/2020
17Sweden49420/06/2020
18Mississippi47427/06/2020
19France42325/05/2020
20Colorado38220/06/2020
21New Hampshire35301/07/2020
22Minnesota35229/06/2020
23Netherlands35115/06/2020
24Ireland34920/06/2020
25Georgia33520/06/2020
26New Mexico32503/07/2020
27Ohio31928/06/2020
28Iowa30902/07/2020
29Arizona29728/06/2020
30Alabama27303/07/2020
31Virginia25322/06/2020
32Missouri22326/06/2020
33Nevada21424/06/2020
34Washington20408/06/2020
35Nebraska20305/07/2020
36Switzerland19614/06/2020
37North Carolina18103/07/2020
38Luxembourg17923/06/2020
39Wisconsin17927/06/2020
40South Carolina17824/06/2020
41Florida17614/06/2020
42Kentucky16824/06/2020
43California16712/06/2020
44North Dakota15905/07/2020
45Portugal15126/06/2020
46North Macedonia14501/07/2020
47Oklahoma13327/06/2020
48Arkansas12502/07/2020
49South Dakota12318/06/2020
50Kansas12120/06/2020
51Vermont11527/06/2020
52Tennessee11529/06/2020
53Texas11124/06/2020
54Germany10718/06/2020
55Denmark10424/06/2020
56Maine10305/07/2020
57Romania8501/07/2020
58Utah7930/06/2020
59Austria7821/06/2020
60Idaho7304/07/2020
61West Virginia6807/07/2020
62Turkey6227/06/2020
63Finland5930/06/2020
64Oregon5922/06/2020
65Hungary5924/06/2020
66Wyoming5822/07/2020
67Slovenia5326/06/2020
68Estonia5204/07/2020
69Norway4621/06/2020
70Serbia3929/06/2020
71Poland3521/06/2020
72Czechia3301/07/2020
73Montana2905/07/2020
74Iceland2828/06/2020
75Lithuania2829/06/2020
76Bulgaria2820/06/2020
77Croatia2703/07/2020
78Alaska2705/07/2020
79Montenegro2305/07/2020
80Cyprus2203/07/2020
81Malta1818/07/2020
82Hawaii1809/07/2020
83Greece1820/06/2020
84Latvia1613/07/2020
85Slovakia516/07/2020

European countries in italics

Table 2

Means and standard deviations for 50 US states and 35 European countries

USEurope
VariablesMeanS.D.MeanS.D.Definition
Deaths at 50 days1402362330506279Deaths from covid 50 days after onset in country/state
Deaths at 50 days per million225.07319.99112.97153.13Deaths from covid 50 days after onset per million inhabitants
Deaths at 100 days24134833507910545Deaths from covid 100 days after onset in country/state
Deaths at 100 days per million406.99479.54169.10216.75Deaths from covid 100 days after onset per million inhabitants
Population (in millions)4.915.5417.7024.65Population expressed in million inhabitants
Co-residence31.226.1949.1315.62Percent of adults aged 18–34 living with parents;
Missing co-residence000.090.28Missing values in co-residence variable
Population over 65 (%)0.170.020.190.02Population older than 65 over total population in %
Missing Pop over 65000.060.24Missing values in population over 65 variable
Urban (%)73.5914.5772.5112.37Population living in urban areas over total population
Missing urban000.090.28Missing values in variable urban
GDP per capita58722110683654226347Gross domestic product or gross state product
Rental prices16425771350645Rental prices in the capital of the country/state in dollars
Missing rental prices000.110.32Missing values in rental prices variable
Days since onset in France33.487.5230.6910.81Number of days from February 15 to onset
Lockdown measures
  Days to no social events−3.3216.8217.5432.60Number of days from onset to social events ban
  Days to no schools24.8935.5712.1429.69Number of days from onset to schools closure
  Days to no shops3.0813.6510.0923.01Number of days from onset to shops closure
  Days to partial lockdown3.8014.125.1717.84Number of days from onset to partial lockdow
  Days to full lockdown7.688.483.547.15Number of days from onset to full lockdown
  No social events at 100 days1.000.001.000.00Social events ban in place 100 days after onset
  No schools at 100 days0.980.140.430.50Schools closure in place 100 days after onset
  No shops at 100 days0.060.240.140.36Shops closure in place 100 days after onset
  Partial lockdown at 100 days0.000.000.090.28Partial lockdown in place 100 days after onset
  Full lockdown at 100 days0.000.000.090.28Full lockdown in lace 100 days after onset
Tests pc at 86 days0.090.040.060.05Number of tests are measured per one million inhabitants
Missing test pc at 86 days0.000.000.090.28Missing values in Tests pc at 86 days
Hospital beds pc2.630.724.681.67Hospital beds per one thousand inhabitants.
Left-leaning government0.480.500.290.46Goverment is left-leaning
Cumulative deaths from Coronavirus per capita 100 days after the onset of the coronavirus outbreak in that nation/state and date when country/state reached 100 days; observed by summer 2020 European countries in italics Means and standard deviations for 50 US states and 35 European countries A third problem with many previous comparisons of fatalities in the US and Europe is that they tend to be quick at assigning credit or blame to politicians, while overlooking other factors that may contribute to gaps in COVID deaths. We address this problem by taking account of differences in demographic, political, economic, and health-system characteristics. Demographic characteristics include proportion of the population aged 65 or older and proportion of young adults aged 18 to 34 who live with their parents. We also consider variation in the time that elapsed between onset of pandemic in France and its onset in each of the nations/states. After taking account of such factors, we find that US/Europe differences in cumulative deaths from COVID are considerably smaller than the gap in mean deaths per population shown in Table 2 and that the US/Europe gap is not related to whether a nation/state’s government is affiliated with the left or the right. Our main finding is that the large US/Europe gap in cumulative deaths becomes statistically insignificant in our models including various social distance measures and the timing of their implementation. Relative to US states, European countries were more likely to implement them and did so at a faster pace, and this appears to have saved lives.

Methods

We first estimate log-linear regressions of the log of cumulative number of deaths using a sample of 85 nations/states: 35 European countries and 50 US states. Logarithms allow us to interpret coefficients in percentage terms, which facilitates comparability across highly heterogeneous nations/states.3 For example, we estimate Model 1 defined as:where y is the log of cumulative COVID-caused deaths 100 days after the first death in nation/state r, U is a dummy for whether the nation/state is in the USA, POP stands for size of the population, and r indexes state or country. Epsilon is the error term.4 Next, we add X1r to this equation: it is a vector of demographic and economic characteristics including the following explanatory variables: intergenerational co-residence (measured as proportion of those aged 18 to 34 who live with their parents), percent of the population over 65, and percent urban, as well as economic variables (Gross Domestic or State Product per capita and rental prices).5 This gives Eq. 2 Model 3 adds to model 2 by also including X2r, a vector containing the following variables: number of days since first death in France, the square value of this number,6 and whether a government is left-leaning or not. In the case of EU countries we defined ‘left’ as having a government that belongs to the Greens-European Free Alliance, European United Left-Nordic Green Left, or Progressive Alliance of Socialists and Democrats groups in the European parliament; in the case of US states ‘left’ is defined as presence of a governor belonging to the democratic party. Regression Eq. 4 is similar to Eq. 4, except for the fact that it also includes X3r, a vector of social distance measures specifying whether a state or country instituted a full or partial lockdown and number of days it took to implement the measure after the onset of the pandemic in each nation/state. The measures we consider are: full lockdown (all-day but could allow citizens to buy essential items), night curfew or other partial lockdown (could apply only to part of the population), closed schools, closed shops and closed social events.7 We also estimate a model that is similar to Eq. 4, but in addition includes number of hospital beds per capita and number of per capita tests 14 days prior to the day cumulative deaths were measured.8 All variables are defined in Table 2. Sources are specified in Table 6 of the Appendix. Parameter β in all equations above estimates the difference in the conditional mean between US states and European countries. The predicted mean difference between the US (U) and European (E) death rates can then be written aswhere hats indicate predicted values and bars indicate means. This equation could be expanded if there are more than two vectors of explanatory variables. The question of interest to us is: what happens to as more variables are included in the model? To the extent that these variables help explain the difference between European countries and US states the estimated value of β is expected to decrease. Furthermore, the direction of the change is determined by the last terms in Eq. 5. If the mean value of a variable is greater (lower) in the US than in Europe, and it contributes to reducing , the estimate of is expected to be positive (negative). That is, some of the positive difference in the left-hand side that was captured by is now redistributed to the last two terms. For example, to the extent that nations/states with higher income have more deaths, by including GDP per capita in the equation we expect that the coefficient of the US dummy will go down as some of the differential mortality is captured by differences in state/country income.

Findings

Regression results based on Eqs. 1–4 are reported in Table 3 (columns 1 to 4), where cumulative deaths are measured 100 days after onset in each country or state. The five regressions in Table 3 each include a dummy for US and population size, a central determinant of cumulative deaths. When these are the only variables taken into consideration (Model 1 in column 1) we find that the logarithm of cumulative deaths 100 days after onset is 1.3 higher in a US state than in a European country. This implies that cumulative deaths are 130% higher in a US state. On average, according to Table 2 cumulative deaths per capita were 169 in a European country. Multiplying this number by 1.3 gives 220 more cumulative deaths per capita for a US state according to model 1, which implies a total of 389 deaths per capita in a US state.
Table 3

The US-Europe differential in regressions of log of cumulative covid-19 deaths measured 100 days after onset

(1)(2)(3)(4)(5)
VariablesModel 1Model 2Model 3Model 4Model 5
US1.302*** (0.374)0.995** (0.497)1.111*** (0.419)0.404 (0.535)0.234 (0.636)
Population size0.0810*** (0.0130)0.0660*** (0.0112)0.0549*** (0.0129)0.0575*** (0.0142)0.0628*** (0.0165)
Co-residence0.0314** (0.0152)0.0263** (0.0129)0.0172 (0.0139)0.0181 (0.0149)
Missing co-residence−1.176 (1.170)−1.575** (0.747)−1.395 (0.919)−1.345 (0.999)
% over 650.787 (10.28)0.843 (8.164)4.802 (8.246)6.770 (8.929)
Missing % over 653.264*** (1.149)2.759*** (0.715)2.559*** (0.767)4.422*** (1.435)
% urban0.0386*** (0.0137)0.0268** (0.0122)0.0265* (0.0138)0.0240 (0.0159)
Missing % urban−2.527*** (0.501)−2.059*** (0.368)−1.366* (0.716)−3.865** (1.753)
GDP pc3.91e-06 (1.33e-05)−4.27e-06 (1.21e-05)2.67e-06 (1.26e-05)6.87e-06 (1.47e-05)
Rental prices0.000533* (0.000308)0.000546** (0.000258)0.000471* (0.000266)0.000336 (0.000323)
Missing rental prices−2.455* (1.298)−1.359* (0.724)−1.726* (0.940)−2.845** (1.275)
Days since onset in France0.0794 (0.0513)0.120 (0.0882)0.124 (0.0889)
Days since onset in Fr., squared−0.00255*** (0.000794)−0.00278** (0.00120)−0.00271** (0.00123)
Days until no social events0.00428 (0.00675)0.00752 (0.00733)
Days until no schools0.00432 (0.00476)0.00512 (0.00510)
Days until no shops−0.0143 (0.0129)−0.0127 (0.0137)
Day until partial lockdown−0.00136 (0.00989)−0.00519 (0.0106)
Days until full lockdown0.0189 (0.0255)0.0256 (0.0279)
No Schools at 100 days0.584 (0.436)0.463 (0.479)
No Shops at 100 days0.912 (0.592)0.825 (0.693)
Lockdown at 100 days−0.927 (0.802)−0.858 (1.022)
Tests pc at 86 days7.627 (12.48)
Missing tests pc2.103* (1.232)
Hospital beds per 1000−0.0128 (0.201)
Missing beds0.0224 (1.192)
Beds x test pc−1.451 (2.695)
Leftist government0.169 (0.293)0.191 (0.307)0.0892 (0.351)
Constant4.857*** (0.340)0.180 (2.792)1.853 (2.642)0.0287 (2.879)−0.454 (3.554)
Observations8585858585
R-squared0.4150.6210.7440.7680.776

For variable definitions see Table 2 and Appendix Table. Robust standard errors in parentheses

***p < 0.01, **p < 0.05, *p < 0.1

The US-Europe differential in regressions of log of cumulative covid-19 deaths measured 100 days after onset For variable definitions see Table 2 and Appendix Table. Robust standard errors in parentheses ***p < 0.01, **p < 0.05, *p < 0.1 Model 2 presented in Column 2 adds the following demographic and economic variables to the regression in Column 1 that was based on Eq. 1: share of young adults living with their parents, the proportion of the population aged 65 or older, percent urban, GDP or State Product per capita, rental price and dummies indicating that some of these variables have missing values (see Table 7 of Appendix for details about missing values). By adding these variables we see that the US/EUROPE differential in cumulative deaths shrinks to being 100% higher in a US state, which translates into a doubling in the number of deaths, on average from 169 for a European country to 338 for a US state. Model 3 reported in Column 3 includes three additional variables: date of onset of the pandemic in a particular country, the square value of days since onset, and whether the government of a nation/state is left-leaning. Adding these variables is associated with a slight increase in the intercontinental differential: the coefficient of US in the regression rises, implying that the US/Europe differential increases to 110%. The model shown in Col. 4 adds various types of social distance measures to Model 3. It corresponds to Eq. 4 above. By adding these measures the US/Europe differential in cumulative deaths shrinks considerably: from 110% based on column 3 to a value that is statistically insignificant and thus not different from zero. Finally, the model in column 5 indicates that by adding information on tests and beds to the model in column 4 the US/Europe differential continues to be statistically insignificant. Here we also add dummies when variables are missing for particular countries. The differences in the coefficient of US state across the 5 models in Table 3 can be explained with the help of Eq. 5, interpreting X1 and X2 as different (vectors of) explanatory variables added to the model. When comparing models 1 and 2 we see that the US/Europe differential in cumulative mortality shrinks, reflecting the addition of the following variables that favor the spread of the virus and that have a higher mean value in the US than in Europe: rental prices and percent urban. On average US states are slightly more urban and more urban states/countries have had more fatalities. In contrast, the US coefficient is expected to be larger in Model 2 that also includes share of multi-generational coresidence: the US has lower coresidence rates, and coresidence is associated with higher mortality. However, relative to European countries, the US suffers more mortality where intergenerational cohabitation is higher (as shown in Aparicio and Grossbard, 2020a).9 From model 3 it can be seen that the later the pandemic started in a particular area the lower the number of cumulative deaths, as apparent from the coefficient of the squared value of ‘Days since onset in France’.10 As we add that variable to the model we see that the US/Europe differential rises slightly, given that, on average, COVID epidemics started later in US states than in European countries (the mean time that elapsed between first onset in the West and onset for a US state is 33.5 days; it is 30.7 for a European country). This suggests that the US was favored by the delay in experiencing the first Covid cases. It can be noticed that whether a government is left-leaning or not is not associated with differences in cumulative deaths once all the other variables are included in the regression models. This continues to be the case in the models reported in columns 4 and 5. What could account for the substantial reduction in the coefficient of US state in column 4, after the addition of social distance measures? First, European countries took less time to close schools (on average, 12.1 days after onset, versus 24.9 days in the US) and to impose full lockdowns in case of full lockdown (on average 3.5 days from onset versus 7.7 days in the US). Second, 100 days after onset in 14 percent of European countries shops were closed (versus in 6 percent of US states) and in 9 percent of European countries there was a partial lockdown (versus zero percent in US states). Even though the results in Col. 4 do not indicate that any of these measures had statistically significant effects on cumulative death rates the presence of the extra vector of variables related to social distance measures does matter and other studies have shown that how quickly lockdowns were imposed was associated with fewer cases or fewer deaths (e.g. Pei et al 2020). We don’t expect the reduced coefficient of US state to be explained by the fact that on average US states closed shops faster (3 days after onset, versus 10 days after onset in European countries) and were faster at imposing a partial lockdown if it was imposed (3.8 days after onset, versus 5.2 days in Europe). The results in column 5 suggest that little explanatory power is added by including information on hospital beds per capita and COVID tests performed 86 days after onset. Our results don’t support or deny the possibility that lives were saved thanks to additional hospital beds. European countries had extra hospital beds (an average of 4.7 versus an average of 2.6 in US states). On average, more tests were given in US states than in European countries, however these tests differences do not seem to be at the origin of the extra deaths in the US. We include dummies for missing values and it appears that the coefficients of these dummies are often statistically significant. Given that we only have a total of 85 countries or states and some data are missing for 6 European countries (no data are missing for US states) these dummies capture peculiarities unique to the countries missing that information. For instance, we miss information on proportion urban in Cyprus, Macedonia and Turkey. These three countries have fewer cumulative deaths for reasons we can’t identify. Table 4 suggests that the US/Europe differential has grown over time. We reestimated the regressions presented in Table 3, where cumulative deaths are measured 100 days past onset, and instead measured deaths at 50 days past onset. It can be seen that after 50 days the rough differential reported in Column 1 was smaller than after 100 days: cumulative deaths are 90 percent higher in the US, not 130 percent higher, when we only control for population size. Comparing the coefficient of US in Column 1 of Tables 3 and 4 suggests that the US/Europe gap in cumulative deaths has grown over time, as countries and states remain exposed to COVID for a longer time. Furthermore, at 50 days past onset, as soon as we add demographic and economic control variables the US/Europe differential becomes statistically insignificant (Column 2). The differential continues not to be significantly different from zero in the models presented in columns 3 to 5.
Table 4

The US-Europe differential in regressions of log of cumulative covid-19 deaths measured 50 days after onset

(1)(2)(3)(4)(5)
VariablesModel 1Model 2Model 3Model 4Model 5
US0.921** (0.371)0.652 (0.485)0.690 (0.426)0.135 (0.579)−0.0239 (0.633)
Population size0.0763*** (0.0120)0.0604*** (0.0108)0.0552*** (0.0134)0.0536*** (0.0139)0.0566*** (0.0150)
Co-residence0.0356** (0.0149)0.0307** (0.0130)0.0213 (0.0156)0.0249 (0.0159)
Missing co-residence−0.517 (1.037)−1.096 (0.728)0.0375 (1.009)0.712 (1.996)
% over 654.424 (9.727)3.685 (8.180)2.533 (8.673)4.957 (9.093)
Missing propor65over2.795*** (1.019)2.276*** (0.722)2.484*** (0.884)
% urban0.0375*** (0.0132)0.0259** (0.0123)0.0217 (0.0148)0.0201 (0.0164)
Missing % urban−2.271*** (0.477)−1.871*** (0.381)−1.808*** (0.676)
GDPpc1.09e-05 (1.34e-05)3.71e-06 (1.27e-05)5.31e-06 (1.51e-05)1.64e-05 (1.61e-05)
Rental prices0.000444 (0.000314)0.000462* (0.000275)0.000427 (0.000300)0.000270 (0.000358)
Missing rental prices−2.760** (1.118)−1.745** (0.721)−2.167** (0.953)−2.930 (2.355)
Days since onset in France0.107** (0.0519)0.134 (0.101)0.156 (0.0971)
Days since onset in Fr., squared−0.00271*** (0.000776)−0.00271** (0.00133)−0.00278** (0.00129)
Days until No social events0.00104 (0.00743)0.00358 (0.00804)
Days until No schools0.00622 (0.00529)0.00750 (0.00535)
Days until No shops−0.00750 (0.0130)−0.00525 (0.0137)
Days until partial lockdown0.00855 (0.0121)0.00832 (0.0142)
Days until full lockdown0.0188 (0.0269)0.0205 (0.0281)
No Schools at 50 days0.899* (0.517)0.933* (0.517)
No Shops at 50 days0.0751 (0.526)0.000877 (0.530)
Partial lockdown @50 days−0.960 (0.768)−1.262 (0.925)
Full lockdown @50 days1.172 (0.767)1.377 (0.911)
Harsh lockdown @50 days0.182 (0.646)0.434 (0.636)
Tests pc at 36 days8.620 (22.04)
Hospital beds per 10000.0246 (0.177)
Beds x tests−5.583 (6.256)
Left0.293 (0.298)0.305 (0.343)0.306 (0.351)
Constant4.569*** (0.331)−1.061 (2.679)−0.0939 (2.698)−0.974 (3.280)−2.173 (3.532)
Observations8585858581
R-squared0.3880.6110.7170.7490.723

***p < 0.01, **p < 0.05, *p < 0.1

The US-Europe differential in regressions of log of cumulative covid-19 deaths measured 50 days after onset ***p < 0.01, **p < 0.05, *p < 0.1 To test for the robustness of our results we also estimated regressions using deaths per million inhabitants as an alternative dependent variable (available upon request). Results support our findings that measures such as school closings and lockdowns, and how soon they were implemented, help explain the US/EUROPE gap in Covid deaths. We also estimated regressions of the mortality rate, measured as number of deaths per COVID case. The same 5 models specified in Section 2 were estimated, but now with a different dependent variable. Results are reported in Table 5. It can be seen that the coefficient of the US dummy is negative in all regressions and it grows in absolute value as we add an increasingly large number of explanatory variables. The negative coefficient indicates that given the number of cases identified 100 days after onset of COVID in a particular country or state fewer people died per case in a US state than in a European country. To explain the contrast with the US dummy coefficient in Table 3, which was positive, we note that per capita there were, on average, more tests in US states than in European countries (Table 2). Consequently, more cases were identified and the numerator is larger, on average, in a US state than in a European country. It is also possible that COVID has been less likely to lead to deaths in the US, conditional on number of cases.
Table 5

Regressions of mortality rate per COVID case (deaths per case measured 100 days after onset)

(1)(2)(3)(4)(5)
VariablesModel 1Model 2Model 3Model 4Model 5
US−30.44** (11.96)−49.34** (21.07)−45.12** (19.94)−64.55* (33.47)−69.61* (36.08)
Population size−0.0207 (0.222)0.00497 (0.234)−0.159 (0.266)−0.102 (0.257)0.0779 (0.303)
Co-residence0.645 (0.471)0.657 (0.466)0.200 (0.347)0.312 (0.390)
Missing co-residence4.854 (12.34)14.30 (15.43)19.39 (25.78)−0.412 (26.86)
% over 65−296.3 (323.3)−227.6 (314.4)−47.83 (144.6)−40.96 (159.1)
Missing % over 6528.79 (22.08)21.61 (19.48)45.80* (25.91)30.95 (20.38)
% urban−0.408 (0.604)−0.396 (0.639)−0.531 (0.584)−0.573 (0.681)
Missing % urban−35.84* (18.85)−32.40* (17.42)−22.36 (20.92)−24.69 (26.88)
GDPpc0.000835* (0.000490)0.000846* (0.000474)0.00106* (0.000550)0.00113** (0.000554)
Rental prices0.00563 (0.00641)0.00542 (0.00642)0.00532 (0.00573)0.00173 (0.00614)
Missing rental prices−22.84 (18.09)−11.51 (14.31)−34.69 (26.30)
Days since onset in France−0.154 (1.384)1.341 (2.839)1.836 (2.808)
Days since onset in Fr., squared−0.00827 (0.0196)−0.0132 (0.0344)−0.0158 (0.0338)
Days until No social events0.402 (0.274)0.455 (0.327)
Days until No schools−0.0388 (0.0846)−0.0428 (0.0915)
Days until No shops−0.471 (0.375)−0.436 (0.350)
Days until partial lockdown−0.0133 (0.390)−0.0623 (0.378)
Days until full lockdown1.305 (0.972)1.133 (0.878)
No Schools at 100 days14.02 (18.80)15.21 (19.84)
No Shops at 100 days36.71 (43.76)41.12 (43.14)
Partial lockdown at 100 days−44.97 (51.38)−57.87 (51.53)
Tests pc at 86 days−188.3 (244.8)
Missing tests pc36.98 (42.20)
Hospital beds per 1000−7.098 (6.127)
Missing beds−47.12 (48.35)
Beds x test pc29.99 (59.32)
Left−8.290 (8.219)−8.274 (8.253)−11.22 (7.770)
Constant30.65** (12.83)49.96 (71.69)52.44 (80.59)−12.67 (62.58)9.029 (78.79)
Observations8484848484
R-squared0.1460.3590.3820.4930.518

***p < 0.01, **p < 0.05, *p < 0.1

Regressions of mortality rate per COVID case (deaths per case measured 100 days after onset) ***p < 0.01, **p < 0.05, *p < 0.1 Comparing model 3 in col. 3 (without controls for social distance measures) with the model in col. 4 (including social distance measures) we see that the US dummy rises in absolute value, from −45 to −65. This increase in coefficient is not statistically significant. In both columns 4 and 5 the coefficient of the US dummy is only significant at the 10% level; it was so at the 5% level in cols. 1 to 3. From Table 5 we can’t derive the conclusion that US/Europe differentials in the use of social distance measures account for higher mortality in the US. Few variables have a statistically significant coefficient in Table 5, an exception being a positive coefficient of GDP per capita, especially in col. 5 where we also control for hospital beds: richer countries and states may offer better medical care. We prefer our main results reported in Table 3 where the log of cumulative deaths is the dependent variable to the results in Table 5 which depend on both cumulative deaths and number of measured cases, in view of possible measurement errors in both cases and deaths, and the difficulty of establishing whether a variable affects number of cases, number of deaths per case, or both.

Conclusions

Using a sample of 50 US states and 35 European countries we find that 100 days after onset of the COVID pandemic in a particular state or country the US/Europe gap in cumulative deaths stands at 130% when we only control for population size. Given that on average a European country had 169 deaths this implies that on average a US state had 350 cumulative deaths. When we control for other demographic factors and some economic factors, the gap shrinks to 100%. Once we also control for national or state differences in social distancing measures related to COVID the US-Europe gap shrinks considerably and becomes statistically insignificant. This suggests that various types of social distance measures such as school closings and lockdowns, and how soon they were implemented, help explain the gap in cumulative deaths. Relative to US states, European countries were more likely to implement them and did so at a faster pace. There is much left for further research to establish. We hope that our estimations will be computed with better statistics on deaths from COVID (such as comparisons of number of deaths before and after COVID), better health policy data, and based on a larger sample of countries. It would also be useful to further explore our findings at a more detailed level, such as the US counties, European provinces, or other sub-national levels. There have been studies estimating determinants of fatalities using data for small geographic units in the US (e.g. Ahammer et al. 2020) or Europe (e.g. Arpino et al. 2020, Belloc et al. 2020, Laliotis and Minos 2020). Insights could also be gained from combining such sub-national data from the US and Europe, but pooling large sets of data for small geographic units in the USA and Europe is a complex task that has not been undertaken yet. We also hope that further research will keep track of further changes in lockdown policy, beyond the measures taken in the first 100 days of the pandemic and covered in this study.
Table 6

Data sources

VariableEU countriesUS statesYear MeasuredDownloaded on
Covid deaths https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases https://github.com/nytimes/covid-19-data/blob/master/us-states.csv 2020August 3, 2020
Demographics
 Total population, and % over 65 https://appsso.eurostat.ec.europa.eu/nui/submitViewTableAction.do https://data.census.gov/cedsci/table?q=S0102&tid=ACSST1Y2018.S0102 2018May 11, 2020
 % Urban population https://population.un.org/wup/DataQuery/ https://www.icip.iastate.edu/tables/population/urban-pct-states 2010May 16, 2020
 Intergenerational co-residence (% aged 18–34 living w their parents) http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=ilc_lvps08& https://data.census.gov/cedsci/table?q=Young%20Adults,%2018-34%20Years%20Old,%20Living%20At%20Home%20by%20state&g=0100000US.04000.001&hidePreview=true&tid=ACSDT1Y2018.B09021&vintage=2018&layer=VT_2018_040_00_PY_D1&cid=B09021_008E 2018April 23, 2020
Economic variables
 Rental Prices https://www.ubs.com/microsites/prices-earnings/en/ https://www.zillow.com/research/data/ 2020May 8, 2020
 Gross Domestic or State Product in dollars (per capita) https://data.worldbank.org/indicator/NY.GDP.PCAP.CD https://www.bea.gov/ https://www2.census.gov/programs-surveys/popest/tables/2010-2016/state/totals/nst-est2016-01.xlsx 2018April 29, 2020
Health-related variables
 Number of testsa https://ourworldindata.org/grapher/full-list-total-tests-for-covid-19 https://covidtracking.com/api 2020August 3, 2020
 Days from 1st death to lockdownb https://github.com/OlivierLej/Coronavirus_CounterMeasures https://github.com/OlivierLej/Coronavirus_CounterMeasures 2020April 25, 2020
 Hospital beds (per 1000 inhabitants)c https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2019_4dd50c09-en http://ghdx.healthdata.org/record/united-states-hospital-beds-1000-population-state 2017June 25, 2020

aThe number of tests was measured 14 days prior to the number of fatalities

bNumber of days from February 15, when the first Covid death in our sample was reported in France, to the first death in a particular country

cData for Bulgaria, Croatia, Romania and Serbia is from https://ourworldindata.org/

Table 7

Missing values among European countries, by country

Missing information on
CountryCo-residence% UrbanProportion 65+Rental PricesTests pc @86Beds
Cyprus010011
Iceland100100
Malta000101
Montenegro100111
North Macedonia011111
Turkey111000
  4 in total

1.  Is time our ultimate ally in defying the pandemic?

Authors:  Giovanni Landoni; Davide Losi; Stefano Fresilli; Stefano Lazzari; Pasquale Nardelli; Riccardo Puglisi; Alberto Zangrillo
Journal:  Pathog Glob Health       Date:  2020-06-27       Impact factor: 2.894

2.  Data from the COVID-19 epidemic in Florida suggest that younger cohorts have been transmitting their infections to less socially mobile older adults.

Authors:  Jeffrey E Harris
Journal:  Rev Econ Househ       Date:  2020-08-22

3.  Intergenerational residence patterns and Covid-19 fatalities in the EU and the US.

Authors:  Ainoa Aparicio Fenoll; Shoshana Grossbard
Journal:  Econ Hum Biol       Date:  2020-10-29       Impact factor: 2.184

4.  Differential effects of intervention timing on COVID-19 spread in the United States.

Authors:  Sen Pei; Sasikiran Kandula; Jeffrey Shaman
Journal:  Sci Adv       Date:  2020-12-04       Impact factor: 14.136

  4 in total
  1 in total

1.  The Impact of COVID-19 on the Initiation of Clinical Trials in Europe and the United States.

Authors:  Florian Lasch; Eftychia-Eirini Psarelli; Ralf Herold; Andrea Mattsson; Lorenzo Guizzaro; Frank Pétavy; Anja Schiel
Journal:  Clin Pharmacol Ther       Date:  2022-02-17       Impact factor: 6.903

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.